Doctors discuss bioweapons

Possible threats and protection of sensitive research explored at medical meeting.

Written byEugene Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON, D.C.—At its recent meeting, held October 2-5, the World Medical Association for the first time focused its scientific sessions on the growing threat of bioterrorism and biological weapons. The talks were intended to advise physicians attending from 27 nations on the state of the threat and to help national medical associations form their own policies regarding bioterrorism.

At a session titled, "Working Together Internationally for Bioweapons Prevention," speakers discussed the need to better define and control hazardous pathogens, and suggested ways to do so. John Steinbruner, a professor of public policy at the University of Maryland, reminded the audience that the same science that leads to better therapies can be used to craft pathogenic bioweapons—and that more rigorous regulations on such research are needed.

Echoing similar suggestions recently made to the Centers of Disease Control and Prevention (CDC) by the research community, Steinbruner proposed a conceptual scheme for distinguishing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA